What do systematic reviews say?

Naftopidil vs silodosin (alpha‐blocker)

Naftopidil showed no clear difference in treatment withdrawals for any reason compared with silodosin (alpha‐blocker) (low certainty).

• Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes only
  RR 0.8 [0.52, 1.23]
  4 studies · 659 participants
  Low